Kallikrein Enteric-coated Tablets

It has the effects of dilating blood vessels and improving microcirculation; activating plasmin and reducing blood viscosity; inhibiting phospholipase A2, preventing platelet aggregation, and preventing thrombosis.

The main ingredient of this product is pancreatic kallikreinogenase.

This product is an enteric-coated tablet, which is off-white or light brown in color after removing the coating.

Vasodilator. It improves microcirculation. It is mainly used for microcirculatory disorders, such as diabetic nephropathy, peripheral neuropathy, retinopathy, fundus disease and ischemic cerebrovascular disease. It can also be used as an auxiliary treatment for hypertension.

Orally take 120-240 units at a time and 360-720 units per day on an empty stomach.

Occasionally, there may be allergic reactions such as rash, itching, stomach discomfort, and fatigue, which disappear after stopping the medication.

It is contraindicated in the acute phase of cerebral hemorrhage and other hemorrhagic diseases.

Precautions for children: Not reported Precautions for pregnancy and lactation: Not clear. Precautions for the elderly: Not reported

1. This product cannot be used simultaneously with protease inhibitors. 2. This product has a synergistic effect with angiotensin converting enzyme inhibitors (ACEI).

Keep tightly closed in a cool, dry place.

60u*20s*3 boards

18 months.

Sichuan Shunsheng Pharmaceutical Co., Ltd.

• Founded in:

  2000-07-27

• Address:

  No. 56, Section 3, Jiangdong North Road, Xiaolong Subdistrict Office, Gaoping District, Nanchong City, Sichuan Province

• Tax NO.:

  91511303720887287J

• Registered Funds:

  10.01 million yuan

• Website:

  Log in to view

• Email:

  Log in to view